Your browser doesn't support javascript.
loading
Open-Label Phase II Evaluation of Imatinib in Primary Inoperable or Incompletely Resected and Recurrent Glioblastoma.
Sautter, Lisa; Hofheinz, Ralf; Tuettenberg, Jochen; Grimm, Mario; Vajkoczy, Peter; Groden, Christoph; Schmieder, Kirsten; Hochhaus, Andreas; Wenz, Frederik; Giordano, Frank A.
Afiliação
  • Sautter L; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Hofheinz R; Day Treatment Center (TTZ), Interdisciplinary Tumor Center Mannheim (ITM) and 3rd Medical Clinic, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Tuettenberg J; Department of Neurosurgery, Klinikum Idar-Oberstein, Idar-Oberstein, Germany.
  • Grimm M; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
  • Vajkoczy P; Department of Neurosurgery, Charité University Hospital, Humboldt University Berlin, Berlin, Germany.
  • Groden C; Department of Neuroradiology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Schmieder K; Department of Neurosurgery, Ruhr-University Bochum, Bochum, Germany.
  • Hochhaus A; Department of Internal Medicine II, University Hospital Jena, Jena, Germany.
  • Wenz F; University Medical Center Freiburg, Freiburg, Germany.
  • Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany, frank.giordano@umm.de.
Oncology ; 98(1): 16-22, 2020.
Article em En | MEDLINE | ID: mdl-31514200
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Glioblastoma / Inibidores de Proteínas Quinases / Mesilato de Imatinib / Antineoplásicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Oncology Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha